+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • PDF Icon

    Report

  • 189 Pages
  • October 2019
  • Region: Global
  • Transparency Market Research
  • ID: 4911339
Hemoglobin A1c Testing Market: Scope of the Report

A new study on the global hemoglobin A1c testing market was published. It presents a wealth of information on the key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global hemoglobin A1c testing market. The study offers valuable information about the global hemoglobin A1c testing market, to illustrate how growth will discern during the forecast period of 2019-2027.

Key indicators of market growth, which include Compound Annual Growth Rate (CAGR), are elucidated in The study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the global hemoglobin A1c testing market for the forecast period.

An extensive analysis on leading market players’ business strategies has also been featured in The study on the global hemoglobin A1c testing market. This can help readers understand principal factors to foresee growth in the global hemoglobin A1c testing market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global hemoglobin A1c testing market, which will guide market players in taking decisions in the future.

Key Questions Answered in the Hemoglobin A1c Testing Market Study

  • What is the scope of growth of hemoglobin A1c testing companies in the pharmaceutical drugs sector?
  • What will be the Y-o-Y growth of the hemoglobin A1c testing market between 2019 and 2027?
  • What is the influence of changing trends on the global hemoglobin A1c testing market?
  • Will North America continue to remain the most profitable regional market for hemoglobin A1c testing providers?
  • Which factors will impede the growth of the global hemoglobin A1c testing market during the forecast period?
  • Which are the leading companies in the global hemoglobin A1c testing market?

Research Methodology

A unique research methodology has been utilized to conduct comprehensive research on the growth of the global hemoglobin A1c testing market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the production of the global hemoglobin A1c testing market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of The study on the global hemoglobin A1c testing market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from the hemoglobin A1c testing market leaders. Access to an extensive internal repository and external proprietary databases allows for this report to address specific details and questions about the hemoglobin A1c testing market with accuracy. The study has also used the top-down approach to assess numbers for each segment, and the bottom-up approach to counter-validate them. This has helped in making estimates on the future prospects of the global hemoglobin A1c testing market more reliable and accurate.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemoglobin A1c Testing Market
3.1. Market Overview
3.2. Introduction
3.3. Product Definition
3.4. Industry Evolution / Developments
4. Overview
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Global Hemoglobin A1c Testing Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Recent Approved Brands for HbA1c Test, 2018
5.2. Global Hemoglobin A1c Testing Market: Regulations
5.3. Quantitative Analysis, by Test Type
5.4. Europe Hemoglobin A1c Testing Market Overview
6. Global Hemoglobin A1c Testing Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
6.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
6.3.2. Immunoassay
6.3.3. Boronate Affinity Chromatography
6.3.4. Direct Enzymatic Assay
6.3.5. Others
6.4. Global Hemoglobin A1c Testing Market Attractiveness, by Technology
7. Global Hemoglobin A1c Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
7.3.1. Laboratory Testing
7.3.1.1. Commercial Laboratory
7.3.1.2. Others
7.3.2. Point-of-Care (POC) Testing
7.3.2.1. Hospitals
7.3.2.2. Homecare
7.3.2.3. Clinics
7.3.2.4. Others
7.4. Global Hemoglobin A1c Testing Market Attractiveness, by End-user
8. Global Hemoglobin A1c Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Hemoglobin A1c Testing Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Hemoglobin A1c Testing Market Attractiveness, by Region
9. North America Hemoglobin A1c Testing Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. North America Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
9.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
9.3.2. Immunoassay
9.3.3. Boronate Affinity Chromatography
9.3.4. Direct Enzymatic Assay
9.3.5. Others
9.4. North America Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
9.4.1. Laboratory Testing
9.4.1.1. Commercial Laboratory
9.4.1.2. Others
9.4.2. Point-of-Care (POC) Testing
9.4.2.1. Hospitals
9.4.2.2. Homecare
9.4.2.3. Clinics
9.4.2.4. Others
9.5. North America Hemoglobin A1c Testing Market Value Forecast, by Country, 2017–2027
9.5.1. 1. U.S.
9.5.2. Canada
9.6. North America Hemoglobin A1c Testing Market Attractiveness Analysis
9.6.1. By Technology
9.6.2. By End-user
9.6.3. By Country
10. Europe Hemoglobin A1c Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Europe Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
10.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
10.3.2. Immunoassay
10.3.3. Boronate Affinity Chromatography
10.3.4. Direct Enzymatic Assay
10.3.5. Others
10.4. Europe Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
10.4.1. Laboratory Testing
10.4.1.1. Commercial Laboratory
10.4.1.2. Others
10.4.2. Point-of-Care (POC) Testing
10.4.2.1. Hospitals
10.4.2.2. Homecare
10.4.2.3. Clinics
10.4.2.4. Others
10.5. Europe Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Hemoglobin A1c Testing Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Hemoglobin A1c Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
11.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
11.3.2. Immunoassay
11.3.3. Boronate Affinity Chromatography
11.3.4. Direct Enzymatic Assay
11.3.5. Others
11.4. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
11.4.1. Laboratory Testing
11.4.1.1. Commercial Laboratory
11.4.1.2. Others
11.4.2. Point-of-Care (POC) Testing
11.4.2.1. Hospitals
11.4.2.2. Homecare
11.4.2.3. Clinics
11.4.2.4. Others
11.5. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Hemoglobin A1c Testing Market Attractiveness Analysis
11.6.1. By End-user
11.6.2. By Country/Sub-region
12. Latin America Hemoglobin A1c Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Latin America Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
12.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
12.3.2. Immunoassay
12.3.3. Boronate Affinity Chromatography
12.3.4. Direct Enzymatic Assay
12.3.5. Others
12.4. Latin America Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
12.4.1. Laboratory Testing
12.4.1.1. Commercial Laboratory
12.4.1.2. Others
12.4.2. Point-of-Care (POC) Testing
12.4.2.1. Hospitals
12.4.2.2. Homecare
12.4.2.3. Clinics
12.4.2.4. Others
12.5. Latin America Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Hemoglobin A1c Testing Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Hemoglobin A1c Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Middle East & Africa Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
13.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
13.3.2. Immunoassay
13.3.3. Boronate Affinity Chromatography
13.3.4. Direct Enzymatic Assay
13.3.5. Others
13.4. Middle East & Africa Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
13.4.1. Laboratory Testing
13.4.1.1. Commercial Laboratory
13.4.1.2. Others
13.4.2. Point-of-Care (POC) Testing
13.4.2.1. Hospitals
13.4.2.2. Homecare
13.4.2.3. Clinics
13.4.2.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa Hemoglobin A1c Testing Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis by Company (2018)
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. ARKRAY, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Bio-Rad Laboratories, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Polymer Technology Systems, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Danaher Corporation (Beckman Coulter)
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. F. Hoffmann-La Roche Ltd.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Menarini Group
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sebia
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Siemens Healthineers
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Tosoh Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Trinity Biotech plc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Polymer Technology Systems, Inc.
  • Danaher Corporation (Beckman Coulter)
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • Sebia
  • Siemens Healthineers
  • Tosoh Corporation
  • Trinity Biotech plc.